A week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and more

Data Readoutnegativeobesity drugNegative

AI Analysis

Summary

Sanofi partnered with a TCE startup while Merck announced a $6.7 billion acquisition, and Wave experienced negative obesity trial data. The article covers multiple dealmaking activity as Q1 concludes.

Outcome Details

Wave obesity data failed

Importance:6/10

Sentiment:

-0.30

M&Apartnershipobesityclinical trial failurebolt-on deals

Related Companies

$SNYNF $MRK

Read the original article

Published by Endpoints News on March 28, 2026 10:00 AM

Read Original